Loading data for GLAXF — first visit, this takes a few seconds.
GSK (GLAXF)
OTC Markets OTCPK: GLAXF
· Real-Time Price · USD
25.50
+0.15 (0.59%)
At close: Aug 13, 2026, 2:10 PM
The price, the headline numbers and the latest news, in one place.
GSK (GLAXF) Stock Price, Analysis & Data
0.59% (1D)
| Bid | 24.76 |
| Market Cap | 102.14B |
| Revenue (ttm) | 33.2B |
| Net Income (ttm) | 4.82B |
| 0.29 | |
| 1.59 | |
| 16.04 | |
| 11.59 | |
| P/B (ttm) | 4.28 |
| P/S (ttm) | 3.08 |
| Earnings Date | Oct 28, 2026 |
| Ask | 27.2 |
| Volume | 150 |
| Avg. Volume (20D) | 766 |
| Open | 24.29 |
| Previous Close | 25.35 |
| Day's Range | 24.29 - 24.29 |
| 52-Week Range | 18.99 - 31.48 |
| Analyst | n/a |
| Price Target | n/a |
| Dividends | $0.92 (3.62%) |
| Ex-Dividend Date | Aug 13, 2026 |
About GLAXF
GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through Commercial Operations and Total R&D segments. The company offers specialty medicines that include oncology, respiratory/immunology, inflammation, and inhaled medicines for HIV, respirator...
Industry Drug Manufacturers - General
Sector Healthcare
IPO Date Jan 5, 2010
Employees 66,841
Stock Exchange OTC Markets OTCPK
Ticker Symbol GLAXF
Website https://www.gsk.com
Financial Performance
In 2025, GSK's revenue was 32.67B, an increase of 4.11% compared to the previous year's 31.38B. Earnings were 5.72B, an increase of 121.98%.
Financial StatementsGSK is scheduled to release its earnings on Oct 28, 2026, after market closes.
Analysts project revenue of ... Upgrade
Analysts project revenue of ... Upgrade
Page 1 of 2